Discover 1 curated intelligence briefings related to this specific topic.
While the world focused on CAR-T and mRNA, a quieter revolution in radiopharmaceuticals began. Radioligand therapy is not just a new drug class; it is a fundamental shift in the logistics of survival, turning the cancer cell's own receptors into the trigger for its destruction.
